22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/09/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
44 |
| 08/09/22 | 8-K | Current report filing |
|
|
36 |
| 08/03/22 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 07/29/22 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
7 | |
| 07/25/22 | 8-K | Current report filing |
|
|
29 |
| 07/22/22 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
40 | |
| 07/20/22 | 8-K/A | Current report filing |
|
|
34 |
| 06/21/22 | 8-K | Current report filing |
|
|
2 |
| 06/16/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/15/22 | 8-K | Current report filing |
|
|
9 |
